Nathan Seligson

Five @UF researchers have been selected for our 2024 @AmericanCancer Society Institutional Research Grant Pilot Projects! These grants support our early-stage investigators in #cancer-related research studies. Learn more about their projects: go.ufl.edu/3cf1i3f

FDA approves safety labeling changes regarding DPD deficiency for fluorouracil injection products. fda.gov/drugs/resource… #OCENewsBurst

Dr. Mohammed Gbadamosi has secured an Early Independence Award from the @NIH to launch his independent research career. He is one of only 13 junior scientists nationally to receive an Early Independence Award in 2023. pharmacy.ufl.edu/2023/10/03/dr-…

Dr. Anthony M. Casapao is one of only 12 pharmacists worldwide to be elected as a 2023 Fellow of the @IDSAInfo (Infectious Diseases Society of America). pharmacy.ufl.edu/2023/09/29/dr-…

The study guide you never knew you needed: all the soft tissue translocations I could fit into Lose Yourself by Eminem #PathParody @YamatoSueMitsu

The Ligon lab and Pediatric Cancer Immunotherapy Initiative (PCI2) at UF is hiring a highly motivated veterinary technician! Come join the fight to beat pediatric cancer! tinyurl.com/ufpci2

Integrating pharmacogenomic testing into paired germline/somatic genomic testing can be an efficient method for increasing access to testing. In this perspective, my co-authors and I argue for this approach to extend #PGx testing for patients with cancer. doi.org/10.2217/pgs-20…

Know someone on the hunt for a PGY2 in Oncology or Transplant?? @MUSCPharmRes is looking for a candidate in each specialty- join us tonight to learn more! Links can be found here: linktr.ee/muscpharmres

MM and BMT folks: did you know there is 500% variation in high dose melphalan plasma exposure among MM patients undergoing ASCT? How is it acceptable that we deliver such an extremely important drug in such an unreliable way? Test dose strategies have failed but....

🚨Postdoctoral Fellow Job🚨 Eagerly accepting applications for a postdoc position in my group: labpages.moffitt.org/westj/openings… Come join the dynamic and exciting research environment in the IMO (@mathonco) department!

So proud of my @UFPharmacy students presenting their work at @ctosociety. #ProudPI

On the plane to #CTOS2022! Excited to be back in person for this excellent meeting.

Congrats to @UFHealthCancer member @KileyGraim of @UFCISE, who has received a grant from @theNCI to build a first-of-its-kind database and study genomic information from a range of animals to gain insight into the mechanisms of rare human #cancers: go.ufl.edu/r0yhumo

I am grateful to the @AACPharmacy PGx SIG for their support of our work educating future precision medicine experts at @UFPharmacy. I was unable to attend this year but hope I get to see everyone in 2023! #TwitteRx

Beginning a new chapter soon @UFHealth, so honored and grateful. UF Health chief diversity officer named, begins Aug. 22 ufhealth.org/news/2022/uf-h…

Our latest work is out in @NatureComms. With @fsanchezvega, @WTapMD, Samuel Singer, and colleagues at @MSKSarcoma @MSKCancerCenter, we present a genomic analysis of 2,138 tumors representing 45 subtypes of soft tissue and bone #sarcoma (1/x). 🧵 disq.us/t/48gjq1m

@HuangLabICR discussing homologous recombination and sensitivity to temozolomide plus olaparib in pts with uterine #leiomyosarcoma from clinical trial samples. #sarcoma #ASCO22

All patients had complete response. Treat early. Repeat. Treat early. It’s CML all over again. PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer | NEJM: nejm.org/doi/full/10.10…